Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
MBM-02
DRUG
2 trials
Sponsors
Matrix Biomed, Inc.
Conditions
Biochemical Recurrent Prostate Cancer
Glioblastoma
Glioblastoma Multiforme
Prostate Cancer Recurrent
Phase 2
MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM)
NCT04874506
Matrix Biomed, Inc.
Glioblastoma, Glioblastoma Multiforme
Start: 2021-06-01
End: 2023-08-31
Target: 55
Updated: 2021-05-05
MBM-02 (Tempol) for the Treatment of Biochemical Recurrent Prostate Cancer
NCT04876755
Matrix Biomed, Inc.
Biochemical Recurrent Prostate Cancer, Prostate Cancer Recurrent
Start: 2021-05-30
End: 2023-02-28
Target: 55
Updated: 2021-05-06